EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advancements in the Utilization of Metal Nanoparticles for Breast Cancer Treatment: An In Vivo Studies Update

Mahdiyeh Rahdari, Homa Sadat Hashemi, Seyed Mohamad Ali Hashemi, Ali Nadjafi-Semnani, Saeid Jamalie, Mohammad Hossein Sakhaee, Fariba Zabihi, Seyed Ali Shariat Razavi, Masoumeh Taghdisi Khaboushan, Ghazale Ahmadi

Journal of Lab Animal Research · 2023

DOI: 10.58803/jlar.v2i5.31 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lab Animal Research, 2023. Verfasst von Mahdiyeh Rahdari und 9 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer continues to pose a significant threat to women’s health around the globe, requiring continuous research and innovation in treatment. In recent years, metal nanoparticles have emerged as a promising means of treating breast cancer with greater precision and efficiency. The in vivo studies have indicated that metal nanoparticles, such as gold, silver, and platinum, have demonstrated a remarkable ability to selectively target breast cancer cells while sparing healthy tissue. These nanoparticles’ size, shape, and surface chemistry can be altered to enhance their biocompatibility, stability, and drug-loading capacity. They are also highly versatile for therapeutic applications due to their unique physicochemical properties, such as drug delivery, photothermal therapy, and imaging. This review focuses on recent in vivo studies evaluating metal nanoparticles’ safety and efficacy in treating breast cancer. Several studies have demonstrated that metal nanoparticles can trigger apoptosis, inhibit tumor growth, and reduce metastasis in cancer cells. Furthermore, using these nanoparticles with traditional chemotherapy and radiotherapy has demonstrated a synergistic effect, enhancing treatment efficacy. This review also examines the challenges and concerns associated with the clinical translation of metal nanoparticles. Factors like biocompatibility, pharmacokinetics, and long-term safety profiles are discussed in the context of regulatory approval and patient-specific considerations. In conclusion, this review highlights the evolving landscape of breast cancer treatment with the development of metal nanoparticles, as evidenced by recent in vivo studies. In addition to their therapeutic versatility, these nanoparticles can potentially improve patient outcomes and decrease the burden of breast cancer on society.

Zitieren

APA

Rahdari, M., Hashemi, H. S., Hashemi, S. M. A., Nadjafi-Semnani, A., Jamalie, S., Sakhaee, M. H., Zabihi, F., Razavi, S. A. S., Khaboushan, M. T., & Ahmadi, G. (2023). Advancements in the Utilization of Metal Nanoparticles for Breast Cancer Treatment: An In Vivo Studies Update. Journal of Lab Animal Research. https://doi.org/10.58803/jlar.v2i5.31

Vancouver

Rahdari M, Hashemi HS, Hashemi SMA, Nadjafi-Semnani A, Jamalie S, Sakhaee MH, et al. Advancements in the Utilization of Metal Nanoparticles for Breast Cancer Treatment: An In Vivo Studies Update. Journal of Lab Animal Research. 2023. doi:10.58803/jlar.v2i5.31

BibTeX
@article{Rahdari2023,
  author = {Rahdari, Mahdiyeh and Hashemi, Homa Sadat and Hashemi, Seyed Mohamad Ali and Nadjafi-Semnani, Ali and Jamalie, Saeid and Sakhaee, Mohammad Hossein and Zabihi, Fariba and Razavi, Seyed Ali Shariat and Khaboushan, Masoumeh Taghdisi and Ahmadi, Ghazale},
  title = {Advancements in the Utilization of Metal Nanoparticles for Breast Cancer Treatment: An In Vivo Studies Update},
  journal = {Journal of Lab Animal Research},
  year = {2023},
  doi = {10.58803/jlar.v2i5.31}
}
Kostenlos starten →